Journal of Labelled Compounds and Radiopharmaceuticals Citation Rate 2026

ISSN 0362-4803 eISSN 1099-1344 Wiley GB

Q3 Quartile Verified Publisher

About Journal of Labelled Compounds and Radiopharmaceuticals
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Journal of Labelled Compounds and Radiopharmaceuticals (JLCR) is a peer-reviewed academic journal covering Chemical Reactions and Isotopes and Chemical Synthesis and Analysis, published by Wiley in GB, catalogued under ISSN 0362-4803 (e-ISSN 1099-1344). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.44 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3450 USD).

Journal of Labelled Compounds and Radiopharmaceuticals Citation Rate 2026 — In Context

Journal of Labelled Compounds and Radiopharmaceuticals has a 2025 2-Year Citation Rate (OpenAlex) of 0.44, placing it in the Q3 quartile within the Chemical Reactions and Isotopes research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Journal of Labelled Compounds and Radiopharmaceuticals operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Journal of Labelled Compounds and Radiopharmaceuticals should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Journal of Labelled Compounds and Radiopharmaceuticals against similar journals in the field, use our journal comparison tool.

Submission Tips for Journal of Labelled Compounds and …
  • Budget $3450 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Chemical Reactions and Isotopes, Chemical Synthesis and Analysis, Medical Imaging Techniques and Applications. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Journal of Labelled … Compares
Citation Rate vs Field Avg
-85%
Field avg: 2.89
APC vs Field Avg
-3%
Field avg: $3555

Compared against 12 journals in the same research areas.

ISSN (Print) 0362-4803
ISSN (Online) 1099-1344
Publisher Wiley
Country United Kingdom
APC / Cost $3450 USD
In-depth profile & metrics

Journal of Labelled Compounds and Radiopharmaceuticals is published by Wiley and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 3450.

In our subject taxonomy, Journal of Labelled Compounds and Radiopharmaceuticals is classified under Chemical Reactions and Isotopes, Chemical Synthesis and Analysis, Medical Imaging Techniques and Applications and Radiopharmaceutical Chemistry and Applications.

Journal of Labelled Compounds and Radiopharmaceuticals is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 0.441.

Research Areas
Links
Frequently Asked Questions about Journal of Labelled Compounds and …

Journal of Labelled Compounds and Radiopharmaceuticals does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 0.441 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Journal of Labelled Compounds and Radiopharmaceuticals is not an open access journal.

The Article Processing Charge (APC) for Journal of Labelled Compounds and Radiopharmaceuticals is $3450 USD.

Journal of Labelled Compounds and Radiopharmaceuticals is published by Wiley.

Journal of Labelled Compounds and Radiopharmaceuticals shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Journal of Labelled Compounds and Radiopharmaceuticals is 0362-4803. Its electronic ISSN (eISSN) is 1099-1344.

Journal of Labelled Compounds and Radiopharmaceuticals sits in the Q3 quartile based on its latest impact factor of 0.44, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.441
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.441 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Compare Journals

Compare Journal of Labelled Compounds… against similar publications in its field:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S90602895

Get weekly updates for Chemical Reactions and Isotopes journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google